Cognitive enhancers: consumption of psychostimulants in medicine

Psychostimulants are drugs that can be used to improve cognitive performance by students and health care professionals. This trend might establish a public health issue. The purpose of this study is to describe the prevalence of psychostimulant use in medical students and resident doctors, and to id...

Full description

Autores:
Latella, Andres
Sanchez de Paz, María Pilar
Mata-Suarez, Santiago Miguel
Bignone, Inés
Lerman, Damián
Rojas, Galeno
Tipo de recurso:
Article of journal
Fecha de publicación:
2022
Institución:
Corporación Universidad de la Costa
Repositorio:
REDICUC - Repositorio CUC
Idioma:
eng
OAI Identifier:
oai:repositorio.cuc.edu.co:11323/10141
Acceso en línea:
https://hdl.handle.net/11323/10141
https://repositorio.cuc.edu.co/
Palabra clave:
Psychostimulants
Drugs
Pharmacoepidemiology
Modafinil
Medical students
Psicoestimulantes
Fármacos
Farmacoepidemiología
Modafinilo
Estudiantes de medicina
Rights
openAccess
License
Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
id RCUC2_9defe43c4e1344d0a97656eb7e38f81c
oai_identifier_str oai:repositorio.cuc.edu.co:11323/10141
network_acronym_str RCUC2
network_name_str REDICUC - Repositorio CUC
repository_id_str
dc.title.eng.fl_str_mv Cognitive enhancers: consumption of psychostimulants in medicine
dc.title.translated.none.fl_str_mv Potenciadores cognitivos: uso de psicoestimulantes en el ámbito de la medicina
title Cognitive enhancers: consumption of psychostimulants in medicine
spellingShingle Cognitive enhancers: consumption of psychostimulants in medicine
Psychostimulants
Drugs
Pharmacoepidemiology
Modafinil
Medical students
Psicoestimulantes
Fármacos
Farmacoepidemiología
Modafinilo
Estudiantes de medicina
title_short Cognitive enhancers: consumption of psychostimulants in medicine
title_full Cognitive enhancers: consumption of psychostimulants in medicine
title_fullStr Cognitive enhancers: consumption of psychostimulants in medicine
title_full_unstemmed Cognitive enhancers: consumption of psychostimulants in medicine
title_sort Cognitive enhancers: consumption of psychostimulants in medicine
dc.creator.fl_str_mv Latella, Andres
Sanchez de Paz, María Pilar
Mata-Suarez, Santiago Miguel
Bignone, Inés
Lerman, Damián
Rojas, Galeno
dc.contributor.author.none.fl_str_mv Latella, Andres
Sanchez de Paz, María Pilar
Mata-Suarez, Santiago Miguel
Bignone, Inés
Lerman, Damián
Rojas, Galeno
dc.subject.proposal.eng.fl_str_mv Psychostimulants
Drugs
Pharmacoepidemiology
Modafinil
Medical students
topic Psychostimulants
Drugs
Pharmacoepidemiology
Modafinil
Medical students
Psicoestimulantes
Fármacos
Farmacoepidemiología
Modafinilo
Estudiantes de medicina
dc.subject.proposal.spa.fl_str_mv Psicoestimulantes
Fármacos
Farmacoepidemiología
Modafinilo
Estudiantes de medicina
description Psychostimulants are drugs that can be used to improve cognitive performance by students and health care professionals. This trend might establish a public health issue. The purpose of this study is to describe the prevalence of psychostimulant use in medical students and resident doctors, and to identify consumption related risk factors. The study was conducted through a self-administered, anonymous online survey. 355 respondents were included, 27% (n = 96) were resident doctors, 70.4% (n = 250) students and 2.5% (n = 9) specialists. 17.4% (n = 62) opted for psychostimulant drugs of which modafinil was the most chosen. The most desired effect was to improve wakefulness 83.6% (n = 51). The average age for consumers was 27.31±3.08 (p = 0.033). The multivariate analysis revealed that the predictive variables with highest risk of consumption were: having read the package insert (OR = 5.2; p = 0.0001), previous use of benzodiazepines (OR = 3.75; p = 0.045) and having considered ethical its use (OR=1.03; p = 0.0001). According to literature, the prevalent use of psychostimulants by doctors under training in our population might be higher than other countries. This study is an important source of information for health authorities as it highlights unrestricted access and inappropriate use of psychostimulants.
publishDate 2022
dc.date.issued.none.fl_str_mv 2022-01-20
dc.date.accessioned.none.fl_str_mv 2023-05-17T23:30:25Z
dc.date.available.none.fl_str_mv 2023-05-17T23:30:25Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Latella, A.-N., Sanchez-de-Paz, M.-P., Mata-Suarez, S., Bignone, I., Lerman, D., & Rojas, G. (2022). Cognitive enhancers: Consumption of psychostimulants in medicine. Journal of Applied Cognitive Neuroscience, 2(2), e00233724. https://doi.org/10.17981/JACN.2.2.2021.05
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/11323/10141
dc.identifier.doi.none.fl_str_mv 10.17981/JACN.2.2.2021.05
dc.identifier.eissn.spa.fl_str_mv 2745-0031
dc.identifier.instname.spa.fl_str_mv Corporación Universidad de la Costa
dc.identifier.reponame.spa.fl_str_mv REDICUC - Repositorio CUC
dc.identifier.repourl.spa.fl_str_mv https://repositorio.cuc.edu.co/
identifier_str_mv Latella, A.-N., Sanchez-de-Paz, M.-P., Mata-Suarez, S., Bignone, I., Lerman, D., & Rojas, G. (2022). Cognitive enhancers: Consumption of psychostimulants in medicine. Journal of Applied Cognitive Neuroscience, 2(2), e00233724. https://doi.org/10.17981/JACN.2.2.2021.05
10.17981/JACN.2.2.2021.05
2745-0031
Corporación Universidad de la Costa
REDICUC - Repositorio CUC
url https://hdl.handle.net/11323/10141
https://repositorio.cuc.edu.co/
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournal.spa.fl_str_mv Journal of Applied Cognitive Neuroscience
dc.relation.references.spa.fl_str_mv Barón, L.; Botero-Henao, K.; Castaño Castrillón, J. J.; Castillo-Chang, K.; Díaz-Corrales, J.; Echeverri-Uribe, J. S.; Parra, G. A.; Yepes, J. S.; & Yurgaky-Jordán, H. Y. (2011). Prevalencia y factores asociados al consumo de anfetaminas en estudiantes del Programa de Medicina de la Universidad de Manizales. Revista de la Facultad de Medicina, 59, 201–214. Disponible en https://revistas.unal.edu.co/index.php/revfacmed/article/view/26455
Cakic, V. (2009). Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics, 35(10), 611–615. https://doi.org/10.1136/jme.2009.030882
Dietz, P.; Striegel, H.; Franke, A. G.; Klaus Lieb, K.; Simon, P. & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33(1), 44–50. https://doi.org/10.1002/phar.1166
Eickenhorst, P.; Vitzthum, K.; Klapp, B. F.; Groneberg, D. & Mache, S. (2012). Neuroenhancement Among German University Students: Motives, Expectations, and Relationship with Psychoactive Lifestyle Drugs. Journal of Psychoactive Drugs, 44(5), 418–427. https://doi.org/10.1080/02791072.2012.736845
Fallah, G.; Moudi, S.; Hamidia, A. & Bijani, A. (2018). Stimulant use in medical students and residents requires more careful attention. Caspian Journal of Internal Medicine, 9(1), 87–91. https://doi.org/10.22088/cjim.9.1.87
Franke, A. G.; Bagusat, C.; Rust, S.; Engel, A. & Lieb, K. (2014). Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neuroscience, 264(Suppl 1), 83–90. https://doi.org/10.1007/s00406-014-0537-1
Franke, A. G.; Bonertz, C.; Christmann, M.; Huss, M.; Fellgiebel, A.; Hildt, E. & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44(2), 60–66. https://doi.org/10.1055/s-0030-1268417
Froestl, W.; Muhs, A. & Pfeifer, A. (2014a). Cognitive Enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014. Journal of Alzheimers Disease, 41(4), 961–1019. https://doi.org/10.3233/jad-2012-121186
Froestl, W.; Muhs, A. & Pfeifer, A. (2014b). Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 22014. Journal of Alzheimers Disease, 42(1), 1–68. https://doi.org/10.3233/jad-140402
Froestl, W.; Muhs, A. & Pfeifer, A. (2014c). Cognitive Enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014. Journal of Alzheimers Disease, 42(4), 1079–1149. https://doi.org/10.3233/jad-141206
Handel, D. A.; Raja, A. & Lindsell, C. J. (2006). The Use of Sleep Aids among Emergency Medicine Residents: A Web Based Survey. BMC Health Services Research, 6, 1–8. https://doi.org/10.1186/1472-6963-6-136
IBM SPSS Statistics. (version 23.0). Statistical Package for the Social Sciences. [Software]. New York: International Business Machines Corporation. Available: https://www.ibm.com/products/spss-statistics
Mache, S.; Eickenhorst, P.; Vitzthum, K.; Klapp, B. F. & Groneberg, D. A. (2012). Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences. Wiener Medizinische Wochenschrift, 162(11-12), 262–271. https://doi.org/10.1007/s10354-012-0115-y
Maher, B. (2008). Poll results: look who’s doping. Nature, 452(7188), 674–675. Avaiable: https://www.nature.com/articles/452674a
Mazzoglio, M. J.; Algieri, R. D.; Dogliotti, C. B.; Gazzotti, A. M.; Jiménez-Villarruel, H. N. y Rey, L. M. (2011). Utilización de sustancias psicoactivas en alumnos de anatomía y su implicación en el aprendizaje. Educación Médica, 14(2), 129–132. http://dx.doi.org/10.4321/S1575-18132011000200009
McBeth, B. D.; McNamara, R. M.; Ankel, F. K.; Mason, E. J.; Ling, L. J.; Flottemesch, T. J. & Asplin, B. R. (2009). Modafinil and Zolpidem Use by Emergency Medicine Residents. Academic Emergency Medicine, 16(12), 1311–1317. https://doi.org/10.1111/j.1553-2712.2009.00586.x
Moore, D. R.; Burgard, D. A.; Larson, R. G. & Ferm, M. (2014). Psychostimulant use among college students during periods of high and low stress: an interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data. Addictive Behaviors, 39(5), 987–993. https://doi.org/10.1016/j.addbeh.2014.01.021
Rojas, G.; Demey, I. & Arizaga, R. L. (2013). Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina. Medicina (B Aires), 73(3), 213–223. Available from https://medicinabuenosaires.com/demo/revistas/vol73-13/3/213-223-med%205968-A.pdf
Sánchez, M. P.; Latella, A. N.; Falero, A.; Lerman, D.; Bignone, I. M. I. y Rojas, G. (2021). Análisis de publicidades sobre medicamentos neurológicos recibidos durante la consulta médica. Medicina (B Aires), 81(4), 559–564. Recuperado de https://www.medicinabuenosaires.com/revistas/vol81-21/n4/559.pdf
Shy, B. D.; Portelli, I. & Nelson, L. S. (2011). Emergency medicine residents’ use of psychostimulants and sedatives to aid in shift work. The American Journal of Emergency Medicine, 29(9), 1034–1036. https://doi.org/10.1016/j.ajem.2010.06.004
VNM. (s.f.). Vademecum nacional de medicamento. Disponible en http://anmatvademecum.servicios.pami.org.ar/index.html (consultado el 07/10/19).
Wolff, W.; Brand, R.; Baumgarten, F.; Lösel, J. & Ziegler, M. (2014). Modeling students’ instrumental (mis-) use of substances to enhance cognitive performance: Neuroenhancement in the light of job demands-resources theory. Biopsychosocial Medicine, 8, 1–11. https://doi.org/10.1186/1751-0759-8-1
Zaami, S.; Rinaldi, R.; Bersani, G.; Del Rio, A.; Ciallella, C. & Marinelli, E. (2020). Nootropics use in the workplace: psychiatric and ethical aftermath towards the new frontier of bioengineering. European Review for Medical and Pharmacological Sciences, 24(4), 2129–2139. https://doi.org/10.26355/eurrev_202002_20393
dc.relation.citationendpage.spa.fl_str_mv 9
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationissue.spa.fl_str_mv 2
dc.relation.citationvolume.spa.fl_str_mv 2
dc.rights.license.spa.fl_str_mv Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
https://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 9 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Corporación Universidad de la Costa
dc.publisher.place.spa.fl_str_mv Colombia
dc.source.spa.fl_str_mv https://revistascientificas.cuc.edu.co/JACN/article/view/3724
institution Corporación Universidad de la Costa
bitstream.url.fl_str_mv https://repositorio.cuc.edu.co/bitstreams/7c00d51d-6b23-4816-9d83-a5209890970d/download
https://repositorio.cuc.edu.co/bitstreams/e4583f7b-55e3-4205-9f3c-b4b3afe8d454/download
https://repositorio.cuc.edu.co/bitstreams/165b8b52-f313-468d-a542-ddca4c986797/download
https://repositorio.cuc.edu.co/bitstreams/a45c18ef-4942-4391-b367-d34fe3ffbbae/download
bitstream.checksum.fl_str_mv 4ce17268e8fb4fdb3b1fcedba004c017
2f9959eaf5b71fae44bbf9ec84150c7a
5e4c93c382f5d004b26dee87286f29ee
ad4811ecfe089c2dcd70e9ebe2baf6cc
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio de la Universidad de la Costa CUC
repository.mail.fl_str_mv repdigital@cuc.edu.co
_version_ 1811760671360024576
spelling Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)Copyright (c) 2021 Andres Norberto Latella, María Pilar Sanchez de Paz, Dr., Santiago Mata Suarez, Inés Bignone, Dami´an Lerman, Galeno Rojashttps://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Latella, AndresSanchez de Paz, María PilarMata-Suarez, Santiago MiguelBignone, InésLerman, DamiánRojas, Galeno 2023-05-17T23:30:25Z2023-05-17T23:30:25Z2022-01-20Latella, A.-N., Sanchez-de-Paz, M.-P., Mata-Suarez, S., Bignone, I., Lerman, D., & Rojas, G. (2022). Cognitive enhancers: Consumption of psychostimulants in medicine. Journal of Applied Cognitive Neuroscience, 2(2), e00233724. https://doi.org/10.17981/JACN.2.2.2021.05https://hdl.handle.net/11323/1014110.17981/JACN.2.2.2021.052745-0031Corporación Universidad de la CostaREDICUC - Repositorio CUChttps://repositorio.cuc.edu.co/Psychostimulants are drugs that can be used to improve cognitive performance by students and health care professionals. This trend might establish a public health issue. The purpose of this study is to describe the prevalence of psychostimulant use in medical students and resident doctors, and to identify consumption related risk factors. The study was conducted through a self-administered, anonymous online survey. 355 respondents were included, 27% (n = 96) were resident doctors, 70.4% (n = 250) students and 2.5% (n = 9) specialists. 17.4% (n = 62) opted for psychostimulant drugs of which modafinil was the most chosen. The most desired effect was to improve wakefulness 83.6% (n = 51). The average age for consumers was 27.31±3.08 (p = 0.033). The multivariate analysis revealed that the predictive variables with highest risk of consumption were: having read the package insert (OR = 5.2; p = 0.0001), previous use of benzodiazepines (OR = 3.75; p = 0.045) and having considered ethical its use (OR=1.03; p = 0.0001). According to literature, the prevalent use of psychostimulants by doctors under training in our population might be higher than other countries. This study is an important source of information for health authorities as it highlights unrestricted access and inappropriate use of psychostimulants.Los psicoestimulantes son fármacos que pueden ser utilizados para mejorar el rendimiento cognitivo por los médicos en formación. Esta tendencia representaría un problema de salud pública del cual existe escasa información disponible. Describir la prevalencia del uso de psicoestimulantes en alumnos de medicina y médicos residentes e identificar factores de riesgo asociados al consumo. Encuesta online anónima y autoadministrada. Se analizaron 355 encuestas, 27% (n = 96) fueron médicos residentes, 70.4% (n = 250) estudiantes y 2.5% (n = 9) médicos especialistas. El 17.2% (n = 62) recurrió a drogas psicoestimulantes, de las cuales la más elegida fue el modafinilo (n = 39). El objetivo más buscado fue mejorar la vigilia 83.6% (n = 51). La edad media para los consumidores fue 27.31 ± 3.08 (p = 0.033). En el análisis multivariado se observó que las variables predictoras de mayor riesgo de consumo fueron: haber leído el prospecto (OR = 5.2; p = 0,0001), haber consumido benzodiacepinas previamente (OR = 3.75; p = 0.045) y haber considerado ético su uso (OR = 1.03; p = 0.0001). La prevalencia de uso de psicoestimulantes por médicos en formación en nuestra población podría ser mayor a la de otros países. El presente trabajo representa una importante fuente de información para las autoridades sanitarias dado que destaca el libre acceso y el uso inapropiado de psicoestimulantes.9 páginasapplication/pdfengCorporación Universidad de la CostaColombiahttps://revistascientificas.cuc.edu.co/JACN/article/view/3724Cognitive enhancers: consumption of psychostimulants in medicinePotenciadores cognitivos: uso de psicoestimulantes en el ámbito de la medicinaArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85Journal of Applied Cognitive NeuroscienceBarón, L.; Botero-Henao, K.; Castaño Castrillón, J. J.; Castillo-Chang, K.; Díaz-Corrales, J.; Echeverri-Uribe, J. S.; Parra, G. A.; Yepes, J. S.; & Yurgaky-Jordán, H. Y. (2011). Prevalencia y factores asociados al consumo de anfetaminas en estudiantes del Programa de Medicina de la Universidad de Manizales. Revista de la Facultad de Medicina, 59, 201–214. Disponible en https://revistas.unal.edu.co/index.php/revfacmed/article/view/26455Cakic, V. (2009). Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Journal of Medical Ethics, 35(10), 611–615. https://doi.org/10.1136/jme.2009.030882Dietz, P.; Striegel, H.; Franke, A. G.; Klaus Lieb, K.; Simon, P. & Ulrich, R. (2013). Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Pharmacotherapy, 33(1), 44–50. https://doi.org/10.1002/phar.1166Eickenhorst, P.; Vitzthum, K.; Klapp, B. F.; Groneberg, D. & Mache, S. (2012). Neuroenhancement Among German University Students: Motives, Expectations, and Relationship with Psychoactive Lifestyle Drugs. Journal of Psychoactive Drugs, 44(5), 418–427. https://doi.org/10.1080/02791072.2012.736845Fallah, G.; Moudi, S.; Hamidia, A. & Bijani, A. (2018). Stimulant use in medical students and residents requires more careful attention. Caspian Journal of Internal Medicine, 9(1), 87–91. https://doi.org/10.22088/cjim.9.1.87Franke, A. G.; Bagusat, C.; Rust, S.; Engel, A. & Lieb, K. (2014). Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neuroscience, 264(Suppl 1), 83–90. https://doi.org/10.1007/s00406-014-0537-1Franke, A. G.; Bonertz, C.; Christmann, M.; Huss, M.; Fellgiebel, A.; Hildt, E. & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44(2), 60–66. https://doi.org/10.1055/s-0030-1268417Froestl, W.; Muhs, A. & Pfeifer, A. (2014a). Cognitive Enhancers (Nootropics). Part 1: drugs interacting with receptors. Update 2014. Journal of Alzheimers Disease, 41(4), 961–1019. https://doi.org/10.3233/jad-2012-121186Froestl, W.; Muhs, A. & Pfeifer, A. (2014b). Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 22014. Journal of Alzheimers Disease, 42(1), 1–68. https://doi.org/10.3233/jad-140402Froestl, W.; Muhs, A. & Pfeifer, A. (2014c). Cognitive Enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014. Journal of Alzheimers Disease, 42(4), 1079–1149. https://doi.org/10.3233/jad-141206Handel, D. A.; Raja, A. & Lindsell, C. J. (2006). The Use of Sleep Aids among Emergency Medicine Residents: A Web Based Survey. BMC Health Services Research, 6, 1–8. https://doi.org/10.1186/1472-6963-6-136IBM SPSS Statistics. (version 23.0). Statistical Package for the Social Sciences. [Software]. New York: International Business Machines Corporation. Available: https://www.ibm.com/products/spss-statisticsMache, S.; Eickenhorst, P.; Vitzthum, K.; Klapp, B. F. & Groneberg, D. A. (2012). Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences. Wiener Medizinische Wochenschrift, 162(11-12), 262–271. https://doi.org/10.1007/s10354-012-0115-yMaher, B. (2008). Poll results: look who’s doping. Nature, 452(7188), 674–675. Avaiable: https://www.nature.com/articles/452674aMazzoglio, M. J.; Algieri, R. D.; Dogliotti, C. B.; Gazzotti, A. M.; Jiménez-Villarruel, H. N. y Rey, L. M. (2011). Utilización de sustancias psicoactivas en alumnos de anatomía y su implicación en el aprendizaje. Educación Médica, 14(2), 129–132. http://dx.doi.org/10.4321/S1575-18132011000200009McBeth, B. D.; McNamara, R. M.; Ankel, F. K.; Mason, E. J.; Ling, L. J.; Flottemesch, T. J. & Asplin, B. R. (2009). Modafinil and Zolpidem Use by Emergency Medicine Residents. Academic Emergency Medicine, 16(12), 1311–1317. https://doi.org/10.1111/j.1553-2712.2009.00586.xMoore, D. R.; Burgard, D. A.; Larson, R. G. & Ferm, M. (2014). Psychostimulant use among college students during periods of high and low stress: an interdisciplinary approach utilizing both self-report and unobtrusive chemical sample data. Addictive Behaviors, 39(5), 987–993. https://doi.org/10.1016/j.addbeh.2014.01.021Rojas, G.; Demey, I. & Arizaga, R. L. (2013). Drugs used for cognitive impairment. Analysis of 1.5 million prescriptions in Argentina. Medicina (B Aires), 73(3), 213–223. Available from https://medicinabuenosaires.com/demo/revistas/vol73-13/3/213-223-med%205968-A.pdfSánchez, M. P.; Latella, A. N.; Falero, A.; Lerman, D.; Bignone, I. M. I. y Rojas, G. (2021). Análisis de publicidades sobre medicamentos neurológicos recibidos durante la consulta médica. Medicina (B Aires), 81(4), 559–564. Recuperado de https://www.medicinabuenosaires.com/revistas/vol81-21/n4/559.pdfShy, B. D.; Portelli, I. & Nelson, L. S. (2011). Emergency medicine residents’ use of psychostimulants and sedatives to aid in shift work. The American Journal of Emergency Medicine, 29(9), 1034–1036. https://doi.org/10.1016/j.ajem.2010.06.004VNM. (s.f.). Vademecum nacional de medicamento. Disponible en http://anmatvademecum.servicios.pami.org.ar/index.html (consultado el 07/10/19).Wolff, W.; Brand, R.; Baumgarten, F.; Lösel, J. & Ziegler, M. (2014). Modeling students’ instrumental (mis-) use of substances to enhance cognitive performance: Neuroenhancement in the light of job demands-resources theory. Biopsychosocial Medicine, 8, 1–11. https://doi.org/10.1186/1751-0759-8-1Zaami, S.; Rinaldi, R.; Bersani, G.; Del Rio, A.; Ciallella, C. & Marinelli, E. (2020). Nootropics use in the workplace: psychiatric and ethical aftermath towards the new frontier of bioengineering. European Review for Medical and Pharmacological Sciences, 24(4), 2129–2139. https://doi.org/10.26355/eurrev_202002_203939122PsychostimulantsDrugsPharmacoepidemiologyModafinilMedical studentsPsicoestimulantesFármacosFarmacoepidemiologíaModafiniloEstudiantes de medicinaPublicationORIGINALCognitive enhancers. Consumption of psychostimulants in medicine.pdfCognitive enhancers. Consumption of psychostimulants in medicine.pdfArtículoapplication/pdf439209https://repositorio.cuc.edu.co/bitstreams/7c00d51d-6b23-4816-9d83-a5209890970d/download4ce17268e8fb4fdb3b1fcedba004c017MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.cuc.edu.co/bitstreams/e4583f7b-55e3-4205-9f3c-b4b3afe8d454/download2f9959eaf5b71fae44bbf9ec84150c7aMD52TEXTCognitive enhancers. Consumption of psychostimulants in medicine.pdf.txtCognitive enhancers. Consumption of psychostimulants in medicine.pdf.txtExtracted texttext/plain29003https://repositorio.cuc.edu.co/bitstreams/165b8b52-f313-468d-a542-ddca4c986797/download5e4c93c382f5d004b26dee87286f29eeMD53THUMBNAILCognitive enhancers. Consumption of psychostimulants in medicine.pdf.jpgCognitive enhancers. Consumption of psychostimulants in medicine.pdf.jpgGenerated Thumbnailimage/jpeg13240https://repositorio.cuc.edu.co/bitstreams/a45c18ef-4942-4391-b367-d34fe3ffbbae/downloadad4811ecfe089c2dcd70e9ebe2baf6ccMD5411323/10141oai:repositorio.cuc.edu.co:11323/101412024-09-16 16:41:25.546https://creativecommons.org/licenses/by-nc-nd/4.0/Copyright (c) 2021 Andres Norberto Latella, María Pilar Sanchez de Paz, Dr., Santiago Mata Suarez, Inés Bignone, Dami´an Lerman, Galeno Rojasopen.accesshttps://repositorio.cuc.edu.coRepositorio de la Universidad de la Costa CUCrepdigital@cuc.edu.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